acebutolol has been researched along with Arrhythmia in 46 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol was compared to placebo, propranolol, and quinidine for the suppression of chronic ventricular arrhythmia in three double-blind, randomized crossover studies." | 9.05 | Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. ( Chandraratna, PA, 1985) |
| "The effect of intravenous acebutolol on supraventricular arrhythmias was evaluated in 20 patients, 5 with chronic obstructive pulmonary disease." | 9.04 | Acebutolol in supraventricular arrhythmias. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 9.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "The effect of the beta-blocking drug acebutolol on the severity of cardiac arrhythmias and the incidence of exercise-induced arrhythmias was studied in 15 patients with chronic coronary artery disease using ambulatory Holter monitoring and bicycle ergometry." | 7.66 | The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease. ( Burckhardt, D; Raeder, EA, 1980) |
| " When arrhythmia was induced in dogs with ouabain, the plasma adrenaline and noradrenaline levels increased to 220 +/- 109 and 392 +/- 84 pg/ml, respectively, from the basal levels of 44 +/- 24 and 140 +/- 43 pg/ml." | 7.66 | Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla. ( Iwatsuki, K; Nagayama, T; Nakai, T; Ode, H; Okuda, C; Sakio, H; Yamada, R, 1983) |
| "To assess the effects of intravenously administered acebutolol (1-20 mg every 4 hours for 24 hours) on cardiac rhythm and performance, we studied 72 patients with evolving myocardial infarction." | 7.66 | Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. ( Ahumada, GG; Ambos, HD; Jaffe, AS; Karlsberg, RP; Roberts, R; Sobel, BE, 1979) |
| "Acebutolol (M & B 17,803 A), a new cardioselective beta-adrenergic blocking agent, was given intravenously to 20 selected patients with various cardiac arrhythmias." | 7.65 | Properties of acebutolol in twenty patients with cardiac arrhythmias. ( Biron, P; Lapointe, L; Nadeau, R; Proulx, A; Tremblay, G, 1975) |
| "Acebutolol was discontinued because of side effects in one patient only." | 6.65 | Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study. ( Aronow, WS; Chandraratna, PA; De Soyza, N; Laddu, AR; Shapiro, W; Thompson, CH, 1982) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 6.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol was compared to placebo, propranolol, and quinidine for the suppression of chronic ventricular arrhythmia in three double-blind, randomized crossover studies." | 5.05 | Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. ( Chandraratna, PA, 1985) |
| "The effect of intravenous acebutolol on supraventricular arrhythmias was evaluated in 20 patients, 5 with chronic obstructive pulmonary disease." | 5.04 | Acebutolol in supraventricular arrhythmias. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 5.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "During 10 years of clinical use involving almost 3 million patient-years, acebutolol has become established as a remarkably safe and well-tolerated beta-blocking agent, effective in treating essential hypertension and cardiac arrhythmias." | 4.77 | Acebutolol: ten years of experience. ( De Bono, G; Kaye, CM; Roland, E; Summers, AJ, 1985) |
| "The effect of the beta-blocking drug acebutolol on the severity of cardiac arrhythmias and the incidence of exercise-induced arrhythmias was studied in 15 patients with chronic coronary artery disease using ambulatory Holter monitoring and bicycle ergometry." | 3.66 | The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease. ( Burckhardt, D; Raeder, EA, 1980) |
| " When arrhythmia was induced in dogs with ouabain, the plasma adrenaline and noradrenaline levels increased to 220 +/- 109 and 392 +/- 84 pg/ml, respectively, from the basal levels of 44 +/- 24 and 140 +/- 43 pg/ml." | 3.66 | Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla. ( Iwatsuki, K; Nagayama, T; Nakai, T; Ode, H; Okuda, C; Sakio, H; Yamada, R, 1983) |
| "To assess the effects of intravenously administered acebutolol (1-20 mg every 4 hours for 24 hours) on cardiac rhythm and performance, we studied 72 patients with evolving myocardial infarction." | 3.66 | Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. ( Ahumada, GG; Ambos, HD; Jaffe, AS; Karlsberg, RP; Roberts, R; Sobel, BE, 1979) |
| "A study was carried out in 20 ambulatory patients with various heart diseases and different forms of cardiac arrhythmias to evaluate the anti-arrhythmic effect of acebutolol when given orally(400 mg/day)." | 3.65 | Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report. ( Burckhardt, K; Ebner, F; Raeder, E, 1977) |
| " In particular, the anti-ouabain arrhythmia properties were not dependent upon beta-blocking potency." | 3.65 | [Pharmacology of acebutolol in animals]. ( Basil, B, 1975) |
| "Acebutolol (M & B 17,803 A), a new cardioselective beta-adrenergic blocking agent, was given intravenously to 20 selected patients with various cardiac arrhythmias." | 3.65 | Properties of acebutolol in twenty patients with cardiac arrhythmias. ( Biron, P; Lapointe, L; Nadeau, R; Proulx, A; Tremblay, G, 1975) |
| "Acebutolol is a safe and efficacious drug for the prevention of arrhythmias following coronary surgery." | 2.66 | Prevention by acebutolol of rhythm disorders following coronary bypass surgery. ( Collignon, P; Kulbertus, H; Larbuisson, R; Limet, R; Materne, P, 1985) |
| "Acebutolol appears to be an effective and well-tolerated antiarrhythmic agent in the treatment of VEB and higher grades of ventricular ectopy." | 2.65 | Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study. ( Dhurandhar, R; Dietrich, P; Hungate, EJ; Laddu, A; Lee, G; Lui, HK; Mason, DT, 1983) |
| "Acebutolol was discontinued because of side effects in one patient only." | 2.65 | Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study. ( Aronow, WS; Chandraratna, PA; De Soyza, N; Laddu, AR; Shapiro, W; Thompson, CH, 1982) |
| "Acebutolol was well tolerated by the three patients with chronic obstructive pulmonary disease." | 2.65 | Treatment of premature ventricular complexes with acebutolol. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 2.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol has both antihypertensive and antiarrhythmic effects." | 1.27 | Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. ( Abernethy, DR; Arendt, RM; Greenblatt, DJ, 1985) |
| "Pretreatment with acebutolol, 15 min before starting reperfusion, markedly reduced the arrhythmias." | 1.26 | Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog. ( Chernecki, W; Das, PK; Dhalla, NS; Sharma, GP, 1978) |
| " Our study suggests: 2 The acetyl metabolite was present in concentrations greater than those of acebutolol at all times during the dosing interval in all seven subjects." | 1.26 | Acebutolol metabolite plasma concentration during chronic oral therapy. ( Harrison, DC; Meffin, PJ; Ricks, WB; Winkle, RA, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (97.83) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basil, B | 2 |
| Clark, JR | 1 |
| Coffee, EC | 1 |
| Jordon, R | 1 |
| Loveless, AH | 1 |
| Pain, DL | 1 |
| Wooldridge, KR | 1 |
| Burckhardt, D | 1 |
| Raeder, EA | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Frick, MH | 1 |
| Kala, R | 1 |
| Rosselot, E | 1 |
| Rochette, L | 1 |
| Didier, JP | 1 |
| Moreau, D | 1 |
| Bralet, J | 1 |
| Opie, LH | 1 |
| Shapiro, W | 2 |
| Park, J | 1 |
| Koch, GG | 1 |
| Singh, SN | 1 |
| DiBianco, R | 1 |
| Davidov, ME | 1 |
| Gottdiener, JS | 1 |
| Johnson, WL | 1 |
| Laddu, AR | 3 |
| Fletcher, RD | 1 |
| Yenes, A | 1 |
| Chamorro, H | 1 |
| González, G | 1 |
| Nakai, T | 2 |
| Sakio, H | 1 |
| Nagayama, T | 1 |
| Ode, H | 1 |
| Yamada, R | 2 |
| Okuda, C | 1 |
| Iwatsuki, K | 1 |
| Latini, R | 1 |
| Achilli, L | 1 |
| Lombi, V | 1 |
| Caporicci, D | 1 |
| de Soyza, N | 3 |
| Kane, JJ | 1 |
| Murphy, ML | 1 |
| Doherty, JE | 1 |
| Bissett, JK | 1 |
| Benchimol, A | 1 |
| Desser, KB | 1 |
| Santoso, T | 1 |
| Nursyirwan, EF | 1 |
| Trisnohadi, HB | 1 |
| Manurung, D | 1 |
| Rahman, AM | 1 |
| Abdurahman, N | 1 |
| Lui, HK | 1 |
| Lee, G | 1 |
| Dhurandhar, R | 1 |
| Hungate, EJ | 1 |
| Laddu, A | 1 |
| Dietrich, P | 1 |
| Mason, DT | 1 |
| Aronow, WS | 4 |
| Wong, R | 1 |
| Plasencia, G | 1 |
| Landa, D | 1 |
| Turbow, M | 3 |
| Chandraratna, PA | 2 |
| Thompson, CH | 1 |
| Schroeder, JS | 1 |
| Van Camp, S | 2 |
| Whittaker, K | 2 |
| Lurie, M | 2 |
| Williams, DO | 1 |
| Tatelbaum, R | 1 |
| Most, AS | 1 |
| Ahumada, GG | 1 |
| Karlsberg, RP | 1 |
| Jaffe, AS | 1 |
| Ambos, HD | 1 |
| Sobel, BE | 1 |
| Roberts, R | 1 |
| Dietz, A | 1 |
| Walter, J | 1 |
| Wiese, K | 1 |
| Yusa, T | 1 |
| Matsukawa, S | 1 |
| Shima, T | 1 |
| Anderson, JL | 1 |
| Harrison, DC | 2 |
| Meffin, PJ | 2 |
| Winkle, RA | 2 |
| Chernecki, W | 1 |
| Das, PK | 1 |
| Dhalla, NS | 1 |
| Sharma, GP | 1 |
| Burckhardt, K | 1 |
| Raeder, E | 1 |
| Ebner, F | 1 |
| Ricks, WB | 1 |
| Suzuki, M | 1 |
| Terukina, M | 1 |
| Akamatsu, T | 1 |
| Suzuki, K | 1 |
| Biron, P | 2 |
| Proulx, A | 2 |
| Lapointe, L | 1 |
| Nadeau, R | 2 |
| Tremblay, G | 2 |
| O'Reilly, M | 1 |
| Puddu, PE | 1 |
| Jouve, R | 1 |
| Langlet, F | 1 |
| Guillen, JC | 1 |
| Fornaris, M | 1 |
| Torresani, J | 1 |
| Reale, A | 1 |
| Abernethy, DR | 1 |
| Arendt, RM | 1 |
| Greenblatt, DJ | 1 |
| De Bono, G | 1 |
| Kaye, CM | 1 |
| Roland, E | 1 |
| Summers, AJ | 1 |
| Sugiyama, S | 1 |
| Hattori, M | 1 |
| Miyazaki, Y | 1 |
| Nagai, S | 1 |
| Ozawa, T | 1 |
| Roelofse, JA | 1 |
| Shipton, EA | 1 |
| de V Joubert, JJ | 1 |
| Luus, HG | 1 |
| de Roquefeuil, F | 1 |
| Goupil, C | 1 |
| Fergusson, NV | 1 |
| Dalgleish, JG | 1 |
| Saunders, DA | 1 |
| Singh, BN | 1 |
| Thoden, WR | 1 |
| Ward, A | 1 |
| Materne, P | 1 |
| Larbuisson, R | 1 |
| Collignon, P | 1 |
| Limet, R | 1 |
| Kulbertus, H | 1 |
4 reviews available for acebutolol and Arrhythmia
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Chronic use of acebutolol in the treatment of cardiac arrhythmias.
Topics: Acebutolol; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Humans | 1991 |
Acebutolol: ten years of experience.
Topics: Acebutolol; Adrenergic beta-Antagonists; Age Factors; Animals; Arrhythmias, Cardiac; Blood Circulati | 1985 |
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Topics: Acebutolol; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Vessels; B | 1985 |
14 trials available for acebutolol and Arrhythmia
| Article | Year |
|---|---|
Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Circadian Rhythm; Clini | 1982 |
Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Prema | 1982 |
Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocar | 1983 |
Effect of acebutolol and propranolol on premature ventricular complexes.
Topics: Acebutolol; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1980 |
Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, | 1982 |
Newer antiarrhythmic agents for patients with coronary artery disease.
Topics: Acebutolol; Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1978 |
Acebutolol in supraventricular arrhythmias.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Heart | 1979 |
Effective treatment of supraventricular arrhythmias with acebutolol.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Double-Blin | 1979 |
[Anti-arrhthmic effect of a new beta blocker in long term therapy of ambulatory patients].
Topics: Acebutolol; Adult; Ambulatory Care; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; F | 1977 |
Treatment of premature ventricular complexes with acebutolol.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Drug Evaluation; Humans; Injecti | 1979 |
Acebutolol and oral surgery: plasma levels following a single oral dose.
Topics: Acebutolol; Administration, Oral; Adult; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as To | 1985 |
Acebutolol.
Topics: Acebutolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Ventricles; Humans; Hypertension; | 1985 |
Prevention by acebutolol of rhythm disorders following coronary bypass surgery.
Topics: Acebutolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease | 1985 |
Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Humans; Male; Middle Age | 1985 |
28 other studies available for acebutolol and Arrhythmia
| Article | Year |
|---|---|
A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.
Topics: Adrenergic beta-Antagonists; Anilides; Animals; Arrhythmias, Cardiac; Cats; Dogs; Heart Rate; Isopro | 1976 |
The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Coronary Disease; Electrocardio | 1980 |
Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Blood Pressure; Double-Blind M | 1981 |
[Use of beta blockaders in arrhythmias and ischemic heart disease].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Catechol | 1982 |
Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Cardiac Output; Co | 1984 |
[Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. Experience in 22 cases].
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes, Premature; Electro | 1984 |
Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla.
Topics: Acebutolol; Adrenal Medulla; Anesthesia; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Female | 1983 |
[Plasma catecholamine concentrations in ouabain-induced arrhythmia during acebutolol administration].
Topics: Acebutolol; Adrenal Medulla; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; In Vitro Technique | 1984 |
[Efficacy of acebutolol in hypertensive and arrhythmia patients].
Topics: Acebutolol; Adult; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Hypertension; Male; Middle | 1984 |
The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
Topics: Acebutolol; Administration, Oral; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate | 1980 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide | 1981 |
Suppression of ventricular arrhythmia by acebutolol.
Topics: Acebutolol; Adult; Arrhythmias, Cardiac; Blood Pressure; Drug Evaluation; Electrocardiography; Femal | 1983 |
Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction.
Topics: Acebutolol; Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Creatine Kinase; Electrocardiography; | 1979 |
[Hemodynamic and antiarrythmic actions of acebutolol in clinical anesthesia (author's transl)].
Topics: Acebutolol; Adult; Aged; Anesthesia; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hemodynam | 1977 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds | 1978 |
Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog.
Topics: Acebutolol; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Electrocardiography; | 1978 |
Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report.
Topics: Acebutolol; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Heart | 1977 |
Acebutolol metabolite plasma concentration during chronic oral therapy.
Topics: Acebutolol; Administration, Oral; Arrhythmias, Cardiac; Humans; Time Factors | 1977 |
[Antiarrhythmic effects and blood level of acebutolol as for oral administration (author's transl)].
Topics: Acebutolol; Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; | 1977 |
[Pharmacology of acebutolol in animals].
Topics: Acebutolol; Animals; Arrhythmias, Cardiac; Blood Pressure; Chemoreceptor Cells; Chloroform; Dogs; Dr | 1975 |
Properties of acebutolol in twenty patients with cardiac arrhythmias.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Infusions, Parenteral; Male; Middle A | 1975 |
Prevention of postischaemic ventricular fibrillation by long term beta adrenoceptor blockade with acebutolol in the anaesthetised dog.
Topics: Acebutolol; Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coron | 1986 |
Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood-Brain Barrier; Cats; C | 1985 |
Mechanism of antiarrhythmic action of beta-blocking agents.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Ca | 1985 |
The cardiovascular response to tracheal intubation during anaesthesia for oral surgical procedures. Effects of labetalol, acebutolol and lignocaine on cardiac rhythm.
Topics: Acebutolol; Adult; Anesthesia, Dental; Anesthesia, Intravenous; Arrhythmias, Cardiac; Female; Heart | 1986 |
[Sectral].
Topics: Acebutolol; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension | 1985 |
Acebutolol for premature ventricular contractions: short- and long-term effects.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Time Factors | 1985 |
[Anti-arrhythmic and anti-anginal properties of acebutolol].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardi | 1974 |